Genetic pleiotropy links nearly half of major depression risk variants to gastrointestinal disease in Nature Genetics analysis

Researchers dissected pleiotropy using genome-wide data to quantify shared genetic architecture between depression and cardiovascular, metabolic, gastrointestinal, and immune conditions. Gastrointestinal diseases including IBS, GERD, gallstones, and peptic ulcer showed the strongest correlations, exceeding those for the other categories. The analysis confirmed bidirectional signaling along the gut-brain axis through overlapping loci affecting neurotransmitter pathways and mucosal integrity.

These findings align with prior observational cohorts showing elevated depression incidence in IBS patients and with Mendelian randomization studies that support causal effects from gut inflammation to mood dysregulation. The 12-year mortality gap in depression is partly attributable to these comorbidities rather than depression alone. Funding from the same institution that conducted the work warrants scrutiny for potential selection bias in variant prioritization.

Next steps include functional validation of shared loci in organoid models and testing whether existing anti-inflammatory or microbiome-targeted drugs alter depressive symptoms in genetically stratified cohorts. Clinical guidelines may soon recommend routine GI screening for newly diagnosed depression cases.

Larger multi-ancestry GWAS and longitudinal RCTs will be required to move from correlation to actionable drug repurposing targets.